INDOCO Q2 FY27 results at a glance
INDOCO REMEDIES LTD. Q2 FY27 key results metrics| Quarter | Q2 FY27 |
|---|
| Quarter ended | 30 Sept 2026 |
|---|
| Revenue | ₹507 cr |
|---|
| Revenue YoY | +7.4% |
|---|
| Operating profit | ₹11.99 cr |
|---|
| Operating margin | 2.4% |
|---|
| Net profit | ₹18.38 cr |
|---|
| Net profit YoY | +331.8% |
|---|
| Net profit QoQ | -71.7% |
|---|
| Net margin | 3.6% |
|---|
| Basic EPS | ₹2.11 |
|---|
| TTM revenue | ₹1,863 cr |
|---|
| TTM net profit | ₹31.94 cr |
|---|
| TTM net margin | 1.7% |
|---|
INDOCO Q2 FY27 results: what the numbers say
INDOCO REMEDIES LTD. (INDOCO) has reported its Q2 FY27 results for the quarter ended 2026-09-30. The company posted revenue of ₹507 cr and a net profit of ₹18.38 cr, translating into earnings per share of ₹2.11.
Compared with the same quarter a year earlier, revenue grew by +7.4% and net profit grew sharply by +331.8%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹11.99 cr, an operating margin of 2.4% versus 2.3% a year ago — a gain of 0.1 percentage points.
INDOCO quarter-wise results table
Net profit
₹18.38 cr
+331.8% YoY
Operating profit
₹11.99 cr
+11.0% YoY
INDOCO REMEDIES LTD. (INDOCO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q2 FY272026-09-30 | ₹507 cr | ₹11.99 cr | ₹18.38 cr | 2.4% | 3.6% | ₹2.11 | +331.8% | -71.7% |
| Q1 FY272026-06-30 | ₹466 cr | ₹6.49 cr | ₹64.99 cr | 1.4% | 13.9% | ₹7.09 | — | +400.3% |
| Q4 FY262026-03-31 | ₹456 cr | ₹17.22 cr | -₹21.64 cr | 3.8% | -4.7% | ₹-2.57 | — | +27.4% |
| Q3 FY262025-12-31 | ₹434 cr | -₹0.5 cr | -₹29.79 cr | -0.1% | -6.9% | ₹-3.20 | — | -275.7% |
| Q2 FY262025-09-30 | ₹472 cr | ₹10.8 cr | -₹7.93 cr | 2.3% | -1.7% | ₹-1.00 | — | — |
| TTM (last 4 quarters) | ₹1,863 cr | ₹35.2 cr | ₹31.94 cr | 1.9% | 1.7% | ₹3.43 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
INDOCO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
INDOCO REMEDIES LTD. quarterly income statement| Particulars | Q2 FY272026-09-30 | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 |
|---|
| Revenue / Sales | ₹507 cr | ₹466 cr | ₹456 cr | ₹434 cr | ₹472 cr |
|---|
| Total expenses | ₹495 cr | ₹460 cr | ₹439 cr | ₹435 cr | ₹461 cr |
|---|
| Gross profit | ₹327 cr | ₹308 cr | ₹315 cr | ₹314 cr | ₹326 cr |
|---|
| Operating profit (EBIT) | ₹11.99 cr | ₹6.49 cr | ₹17.22 cr | -₹0.5 cr | ₹10.8 cr |
|---|
| Operating margin | 2.4% | 1.4% | 3.8% | -0.1% | 2.3% |
|---|
| Interest cost | ₹26.91 cr | ₹28.29 cr | ₹45.92 cr | ₹25.64 cr | ₹24.56 cr |
|---|
| Profit before tax | ₹24.19 cr | ₹77.72 cr | -₹25 cr | -₹31.31 cr | -₹13.53 cr |
|---|
| Tax expense | ₹4.72 cr | ₹12.28 cr | -₹1.32 cr | -₹1.86 cr | -₹4.32 cr |
|---|
| Effective tax rate | 19.5% | 15.8% | 5.3% | 5.9% | 31.9% |
|---|
| Net profit (PAT) | ₹18.38 cr | ₹64.99 cr | -₹21.64 cr | -₹29.79 cr | -₹7.93 cr |
|---|
| Net profit margin | 3.6% | 13.9% | -4.7% | -6.9% | -1.7% |
|---|
| Basic EPS | ₹2.11 | ₹7.09 | ₹-2.57 | ₹-3.20 | ₹-1.00 |
|---|
| Diluted EPS | ₹2.11 | ₹7.09 | ₹-2.57 | ₹-3.20 | ₹-1.00 |
|---|
INDOCO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 |
|---|
| Revenue YoY | +7.4% | — | — | — | — |
|---|
| Revenue QoQ | +8.7% | +2.3% | +5.0% | -7.9% | — |
|---|
| Operating profit YoY | +11.0% | — | — | — | — |
|---|
| Operating profit QoQ | +84.7% | -62.3% | +3544.0% | -104.6% | — |
|---|
| Net profit YoY | +331.8% | — | — | — | — |
|---|
| Net profit QoQ | -71.7% | +400.3% | +27.4% | -275.7% | — |
|---|
| EPS YoY | +311.0% | — | — | — | — |
|---|
| EPS QoQ | -70.2% | +375.9% | +19.7% | -220.0% | — |
|---|
INDOCO annual results history
Full-year performance for INDOCO REMEDIES LTD., useful for reading each quarter in context.
INDOCO REMEDIES LTD. annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,793 cr | ₹1,641 cr | ₹1,788 cr | ₹1,640 cr |
|---|
| Total expenses | ₹1,812 cr | ₹1,668 cr | ₹1,645 cr | ₹1,442 cr |
|---|
| Gross profit | ₹1,233 cr | ₹1,127 cr | ₹1,206 cr | ₹1,101 cr |
|---|
| Operating profit (EBIT) | -₹18.98 cr | -₹26.72 cr | ₹143 cr | ₹198 cr |
|---|
| Operating margin | -1.1% | -1.6% | 8.0% | 12.1% |
|---|
| Interest cost | ₹72.85 cr | ₹62.03 cr | ₹34.93 cr | ₹23.75 cr |
|---|
| Profit before tax | -₹106 cr | -₹74.37 cr | ₹136 cr | ₹193 cr |
|---|
| Tax expense | -₹7.81 cr | ₹3.58 cr | ₹38.79 cr | ₹50.54 cr |
|---|
| Effective tax rate | 7.3% | -4.8% | 28.6% | 26.2% |
|---|
| Net profit (PAT) | -₹95.14 cr | -₹73.74 cr | ₹98.46 cr | ₹142 cr |
|---|
| Net profit margin | -5.3% | -4.5% | 5.5% | 8.7% |
|---|
| Basic EPS | ₹-10.31 | ₹-8.00 | ₹10.68 | ₹15.44 |
|---|
| Diluted EPS | ₹-10.31 | ₹-8.00 | ₹10.67 | ₹15.42 |
|---|
Revenue trend and demand read-through
Topline for Q2 FY27 came in at ₹507 cr against ₹472 cr in Q2 FY26, and ₹466 cr in the preceding Q1 FY27 quarter.
On a sequential basis revenue grew +8.7%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹495 cr, or 97.6% of revenue, with operating profit grew +11.0% year on year.
Margins, tax and profitability
Net profit of ₹18.38 cr works out to a net margin of 3.6% compared with -1.7% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, INDOCO REMEDIES LTD. reported profit before tax of ₹24.19 cr, a tax charge of ₹4.72 cr (effective rate 19.5%), interest cost of ₹26.91 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹64.99 cr in Q1 FY27 to ₹18.38 cr in Q2 FY27, a change of -71.7%.
Trailing twelve months and annual context
Across the trailing four quarters INDOCO REMEDIES LTD. has generated revenue of ₹1,863 cr and net profit of ₹31.94 cr, a trailing net margin of 1.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,793 cr with net profit of -₹95.14 cr and EPS of ₹-10.31, versus the prior year where revenue grew +9.2% and profit declined -29.0%.
What to watch in the next INDOCO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
No next results date is available in the board-meeting calendar. Statement figures update when Yahoo Finance makes them available; this is not an immediate exchange-filing feed.
Financial figures here are supplied through Yahoo Finance fundamentals and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
INDOCO results coverage
No results report published for INDOCO yet — our desk covers each quarter within minutes of the filing.
INDOCO results date history
INDOCO REMEDIES LTD. past board meeting dates for financial results| Board meeting date | Purpose | Details |
|---|
| 27 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
More on INDOCO
INDOCO quarterly results FAQs
What were INDOCO REMEDIES LTD. (INDOCO) Q2 FY27 results?
In Q2 FY27 (quarter ended 30 Sept 2026), INDOCO REMEDIES LTD. reported revenue of ₹507 cr and net profit of ₹18.38 cr, a change of +331.8% year on year on +7.4% revenue growth. EPS stood at ₹2.11.
What is INDOCO profit margin in Q2 FY27?
INDOCO REMEDIES LTD. posted a net profit margin of 3.6% and an operating margin of 2.4% in Q2 FY27. On a trailing twelve-month basis, revenue is ₹1,863 cr and net profit ₹31.94 cr.
Did INDOCO results beat the previous quarter?
INDOCO REMEDIES LTD. net profit changed -71.7% quarter on quarter, from ₹64.99 cr in Q1 FY27 to ₹18.38 cr in Q2 FY27.
When are INDOCO REMEDIES LTD. (INDOCO) quarterly results?
INDOCO REMEDIES LTD. has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see INDOCO latest quarterly results?
Results coverage for INDOCO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the INDOCO stock page.
What is INDOCO REMEDIES LTD. annual revenue and profit?
For FY26, INDOCO REMEDIES LTD. reported full-year revenue of ₹1,793 cr and net profit of -₹95.14 cr, with EPS of ₹-10.31.
How many quarterly results has INDOCO declared recently?
INDOCO has held 1 recent board meetings for financial results, the last on 27 Oct 2026.
Results dates: NSE board-meeting calendar. Financial figures: Yahoo Finance fundamentals, not a direct exchange filing feed. Last successful data fetch 28 Oct 2026. Figures can be delayed; results change only when the provider publishes them. For information only, not investment advice.
